Nectar Lifesciences Balance Sheet Annual

Trade

BSE: 532649 | NSE: NECLIFE | ISIN: INE023H01027 | Sector: Biotechnology & Drugs

33.32 -0.68 (-2.00%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	19.81	0.00	0.00	-
Short Term Investments	9.72	0.31	0.46	0.46
Cashand Short Term Investments	29.52	17.87	16.24	24.32
Accounts Receivable- Trade Net	379.19	279.61	446.98	374.83
Total Receivables Net	380.12	444.98	610.73	552.21
Total Inventory	709.15	731.52	721.26	655.32
Other Current Assets Total	165.04	36.83	6.62	6.98
Total Current Assets	1,283.83	1,231.18	1,354.85	1,238.83
Property/ Plant/ Equipment Total- Net	656.06	690.43	765.18	832.15
Intangibles Net	52.39	49.33	43.02	38.36
Long Term Investments	3.08	0.24	0.24	0.24
Note Receivable- Long Term	8.15	7.35	12.26	14.67
Other Long Term Assets Total	187.54	210.69	215.30	263.87
Total Assets	2,191.06	2,189.21	2,390.83	2,388.11
Accounts Payable	419.66	318.75	376.65	342.15
Current Portof LT Debt/ Capital Leases	495.23	68.44	66.08	63.17
Other Currentliabilities Total	57.93	38.32	49.68	58.78
Total Current Liabilities	972.82	890.93	1,003.83	1,187.39
Long Term Debt	140.31	226.16	290.80	127.46
Total Long Term Debt	140.31	226.47	291.08	128.24
Total Debt	635.54	753.83	859.93	903.41
Other Liabilities Total	8.68	7.22	8.02	10.45
Total Liabilities	1,121.81	1,124.62	1,302.93	1,326.08
Common Stock Total	22.43	22.43	22.43	22.43
Retained Earnings( Accumulated Deficit)	1,046.82	709.07	736.68	710.81
Total Equity	1,069.25	1,064.60	1,087.91	1,062.03
Total Liabilities Shareholders' Equity	2,191.06	2,189.21	2,390.83	2,388.11
Total Common Shares Outstanding	22.43	22.43	22.43	22.43
Tangible Book Valueper Share Common Eq	45.34	45.27	46.59	45.65
Cash	-	17.55	15.78	23.87
Property/ Plant/ Equipment Total- Gross	-	1,453.61	1,481.23	1,500.06
Accumulated Depreciation Total	-	-763.18	-716.06	-667.91
Accrued Expenses	-	6.50	8.66	11.29
Notes Payable/ Short Term Debt	-	458.91	502.77	712.00
Capital Lease Obligations	-	0.31	0.28	0.78
Additional Paid- In Capital	-	328.80	328.80	328.80
Other Equity Total	-	4.30	-	-